Continua
Anthony DeBiase is an experienced professional in process development and clinical manufacturing, currently serving as the Director of Digital Process Development & Clinical Manufacturing at Continua since November 2024. Prior roles include Product Manager at Rockwell Automation, where Anthony utilized life science expertise to enhance digital and automation offerings, and Director of Process Development and Clinical Manufacturing at 3DBio Therapeutics, overseeing site operations and ensuring successful clinical production for 3D-bioprinted implants. Anthony's career includes significant roles at Celularity, Inc. and Regeneron Pharmaceuticals, where responsibilities ranged from leading process optimization for cell therapy products to developing advanced biologic manufacturing processes using Process Analytical Technology (PAT). Anthony holds a B.S. in Chemical Engineering from Villanova University, achieved in 2009.
This person is not in the org chart
This person is not in any teams
Continua
Continua is focused on transforming the enterprise through innovative thinking, advanced technologies, and industry expertise. Its team of consultants empowers clients with solutions that span modern data strategies, manufacturing operations solutions, tech transfer, process analytical technology (PAT), and continuous manufacturing. The business primarily serves pharmaceutical, biopharmaceutical, CDMO, CMO, and specialty chemical organizations that are facing growing pressures to leverage OT data, connect disparate systems, and realize higher production to better compete in the marketplace and prepare for the future.